Explore 3 Stock Ideas & Industry Insights Download Free Report
• The stock is classified as a small-cap growth stock; this is a descriptive market classification, not anInvestmentrating.
• The stock is classified as a mid-cap growth stock; this is a descriptive market classification, not anInvestmentrating.
• The stock is classified as a small-cap growth stock; this is a descriptive market classification, not anInvestmentrating.
• The stock is classified as a small-cap growth stock; this is a descriptive market classification, not anInvestmentrating.
• The stock is classified as a small-cap growth stock; this is a descriptive market classification, not anInvestmentrating.
• The stock is classified as a small-cap growth stock; this is a descriptive market classification, not anInvestmentrating.
• The stock is classified as a small-cap growth stock; this is a descriptive market classification, not anInvestmentrating.
• The stock is classified as a small-cap growth stock; this is a descriptive market classification, not anInvestmentrating.
Genus plc (LSE:GNS) shares eased 1.13% to 2,268.0p on 13 November 2026. The animal genetics group was in focus following its preliminary results for the year ended 30 June 2026, published on 10 September 2026.
Oxford Biomedica plc (LSE:OXB) shares eased 1.50% to 527.0p on 13 November 2026. The cell and gene therapy manufacturer was in focus following its half-year results for the six months ended 30 June 2026, published on 22 September 2026.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…